VC-backed Finch Therapeutics goes public
Finch Therapeutics, a a clinical-stage microbiome therapeutics company, has raised $127.5 million for its IPO after pricing its 7.5 million shares at $17 per share.
Finch Therapeutics, a a clinical-stage microbiome therapeutics company, has raised $127.5 million for its IPO after pricing its 7.5 million shares at $17 per share.
Copyright PEI Media
Not for publication, email or dissemination